Cargando…

Thinking beyond Vaccination: Promising Add-On Strategies to Active Immunization and Vaccination in Pandemics—A Mini-Review

There is little doubt that final victories over pandemics, such as COVID-19, are attributed to herd immunity, either through post-disease convalescence or active immunization of a high percentage of the world’s population with vaccines, which demonstrate protection from infection and transmission an...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatzber, Franz, Wonisch, Willibald, Resch, Ulrike, Strohmaier, Wolfgang, Lindschinger, Meinrad, Mörkl, Sabrina, Cvirn, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304478/
https://www.ncbi.nlm.nih.gov/pubmed/37376671
http://dx.doi.org/10.3390/v15061372
_version_ 1785065519590670336
author Tatzber, Franz
Wonisch, Willibald
Resch, Ulrike
Strohmaier, Wolfgang
Lindschinger, Meinrad
Mörkl, Sabrina
Cvirn, Gerhard
author_facet Tatzber, Franz
Wonisch, Willibald
Resch, Ulrike
Strohmaier, Wolfgang
Lindschinger, Meinrad
Mörkl, Sabrina
Cvirn, Gerhard
author_sort Tatzber, Franz
collection PubMed
description There is little doubt that final victories over pandemics, such as COVID-19, are attributed to herd immunity, either through post-disease convalescence or active immunization of a high percentage of the world’s population with vaccines, which demonstrate protection from infection and transmission and are available in large quantities at reasonable prices. However, it is assumable that humans with immune defects or immune suppression, e.g., as a consequence of allograft transplantation, cannot be immunized actively nor produce sufficient immune responses to prevent SARS-CoV-2 infections. These subjects desperately need other strategies, such as sophisticated protection measures and passive immunization. Hypertonic salt solutions attack vulnerable core areas of viruses; i.e., salt denatures surface proteins and thus prohibits virus penetration of somatic cells. It has to be ensured that somatic proteins are not affected by denaturation regarding this unspecific virus protection. Impregnating filtering facepieces with hypertonic salt solutions is a straightforward way to inactivate viruses and other potential pathogens. As a result of the contact of salt crystals on the filtering facepiece, these pathogens become denatured and inactivated almost quantitatively. Such a strategy could be easily applied to fight against the COVID-19 pandemic and other ones that may occur in the future. Another possible tool to fight the COVID-19 pandemic is passive immunization with antibodies against SARS-CoV-2, preferably from human origin. Such antibodies can be harvested from human patients’ sera who have successfully survived their SARS-CoV-2 infection. The disadvantage of a rapid decrease in the immunoglobulin titer after the infection ends can be overcome by immortalizing antibody-producing B cells via fusion with, e.g., mouse myeloma cells. The resulting monoclonal antibodies are then of human origin and available in, at least theoretically, unlimited amounts. Finally, dry blood spots are a valuable tool for surveilling a population’s immunity. The add-on strategies were selected as examples for immediate, medium and long-term assistance and therefore did not raise any claim to completeness.
format Online
Article
Text
id pubmed-10304478
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103044782023-06-29 Thinking beyond Vaccination: Promising Add-On Strategies to Active Immunization and Vaccination in Pandemics—A Mini-Review Tatzber, Franz Wonisch, Willibald Resch, Ulrike Strohmaier, Wolfgang Lindschinger, Meinrad Mörkl, Sabrina Cvirn, Gerhard Viruses Brief Report There is little doubt that final victories over pandemics, such as COVID-19, are attributed to herd immunity, either through post-disease convalescence or active immunization of a high percentage of the world’s population with vaccines, which demonstrate protection from infection and transmission and are available in large quantities at reasonable prices. However, it is assumable that humans with immune defects or immune suppression, e.g., as a consequence of allograft transplantation, cannot be immunized actively nor produce sufficient immune responses to prevent SARS-CoV-2 infections. These subjects desperately need other strategies, such as sophisticated protection measures and passive immunization. Hypertonic salt solutions attack vulnerable core areas of viruses; i.e., salt denatures surface proteins and thus prohibits virus penetration of somatic cells. It has to be ensured that somatic proteins are not affected by denaturation regarding this unspecific virus protection. Impregnating filtering facepieces with hypertonic salt solutions is a straightforward way to inactivate viruses and other potential pathogens. As a result of the contact of salt crystals on the filtering facepiece, these pathogens become denatured and inactivated almost quantitatively. Such a strategy could be easily applied to fight against the COVID-19 pandemic and other ones that may occur in the future. Another possible tool to fight the COVID-19 pandemic is passive immunization with antibodies against SARS-CoV-2, preferably from human origin. Such antibodies can be harvested from human patients’ sera who have successfully survived their SARS-CoV-2 infection. The disadvantage of a rapid decrease in the immunoglobulin titer after the infection ends can be overcome by immortalizing antibody-producing B cells via fusion with, e.g., mouse myeloma cells. The resulting monoclonal antibodies are then of human origin and available in, at least theoretically, unlimited amounts. Finally, dry blood spots are a valuable tool for surveilling a population’s immunity. The add-on strategies were selected as examples for immediate, medium and long-term assistance and therefore did not raise any claim to completeness. MDPI 2023-06-14 /pmc/articles/PMC10304478/ /pubmed/37376671 http://dx.doi.org/10.3390/v15061372 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Tatzber, Franz
Wonisch, Willibald
Resch, Ulrike
Strohmaier, Wolfgang
Lindschinger, Meinrad
Mörkl, Sabrina
Cvirn, Gerhard
Thinking beyond Vaccination: Promising Add-On Strategies to Active Immunization and Vaccination in Pandemics—A Mini-Review
title Thinking beyond Vaccination: Promising Add-On Strategies to Active Immunization and Vaccination in Pandemics—A Mini-Review
title_full Thinking beyond Vaccination: Promising Add-On Strategies to Active Immunization and Vaccination in Pandemics—A Mini-Review
title_fullStr Thinking beyond Vaccination: Promising Add-On Strategies to Active Immunization and Vaccination in Pandemics—A Mini-Review
title_full_unstemmed Thinking beyond Vaccination: Promising Add-On Strategies to Active Immunization and Vaccination in Pandemics—A Mini-Review
title_short Thinking beyond Vaccination: Promising Add-On Strategies to Active Immunization and Vaccination in Pandemics—A Mini-Review
title_sort thinking beyond vaccination: promising add-on strategies to active immunization and vaccination in pandemics—a mini-review
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304478/
https://www.ncbi.nlm.nih.gov/pubmed/37376671
http://dx.doi.org/10.3390/v15061372
work_keys_str_mv AT tatzberfranz thinkingbeyondvaccinationpromisingaddonstrategiestoactiveimmunizationandvaccinationinpandemicsaminireview
AT wonischwillibald thinkingbeyondvaccinationpromisingaddonstrategiestoactiveimmunizationandvaccinationinpandemicsaminireview
AT reschulrike thinkingbeyondvaccinationpromisingaddonstrategiestoactiveimmunizationandvaccinationinpandemicsaminireview
AT strohmaierwolfgang thinkingbeyondvaccinationpromisingaddonstrategiestoactiveimmunizationandvaccinationinpandemicsaminireview
AT lindschingermeinrad thinkingbeyondvaccinationpromisingaddonstrategiestoactiveimmunizationandvaccinationinpandemicsaminireview
AT morklsabrina thinkingbeyondvaccinationpromisingaddonstrategiestoactiveimmunizationandvaccinationinpandemicsaminireview
AT cvirngerhard thinkingbeyondvaccinationpromisingaddonstrategiestoactiveimmunizationandvaccinationinpandemicsaminireview